Cogzid-TZ Injection

Cogzid-TZ is an advanced anti-pseudomonal antibiotic formulation combining Ceftazidime, a third-generation cephalosporin, with Tazobactam, a β-lactamase inhibitor. This combination enhances antibacterial efficacy against resistant gram-negative pathogens commonly encountered in hospital settings.

Cogzid-TZ provides broad coverage and dependable performance in critical infections, making it a preferred choice for clinicians managing severe and complicated cases.

Key Benefits:
• Strong anti-pseudomonal activity
• β-lactamase protection for enhanced efficacy
• Reliable option in resistant hospital pathogens
• Suitable for ICU and severe infections

Indications:
• Complicated urinary tract infections (UTIs)
• Lower respiratory tract infections (LRTIs)
• Sepsis
• Intra-abdominal infections
• Hospital-acquired infections